glp 1 drugs with least side effects Exploring the of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Ozempic, Mounjaro: 6 'Hidden' Side
Description
[97] observed a potential association between semaglutide and NAION, with incidence rates of 4.28 and 7.64 per 1,000 person-years in patients with T2DM and those who were overweight or obese, respectively, over 36 months
If not, youre in trouble. Where Things Go from Here The GLP-1 conversation is still in its early days
Accessed 24 Dec 2021
It is recommended that patients taking Trulicity or another GLP-1 agonist, weigh the benefits of using the medication against the potential risks, particularly when using the drug for a non-diabetic condition such as weight loss
